Analysis of biopharmaceutical formulations by Time Domain Nuclear Magnetic Resonance (TD-NMR) spectroscopy: A potential method for detection of counterfeit biologic pharmaceuticals

J Pharm Sci. 2021 Jul;110(7):2765-2770. doi: 10.1016/j.xphs.2021.03.011. Epub 2021 Mar 18.

Abstract

1H Time-Domain Nuclear Magnetic Resonance (TD-NMR) is used to characterize solutions of antibodies that simulate biologic pharmaceutical formulations. The results from these measurements are compared with those from solutions in which the concentration or identity of the antibody has been altered. TD-NMR is shown to be very sensitive to differences in the amount of antibody in solution, with the ability to detect variations in as low as 2 mg/mL. It is therefore capable, by comparison with data from known formulations, of determining whether a particular sample is likely to be of an authentic biologic formulation. This method expands on the previous use of HPLC, UV/VIS, Near-IR and High-Resolution NMR to detect adulterated pharmaceutical materials. While the sensitivity of the method is high, it is a fingerprinting methodology, illustrating differences but not elucidating their origin. The extracted relaxation times reflect the combined effect of all solutes (antibody, buffer components, etc.) on the solvent (water).

Keywords: Biologic pharmaceuticals; Counterfeit; Monoclonal antibodies; Nmr spectroscopy; Relaxation times.

MeSH terms

  • Biological Products*
  • Chromatography, High Pressure Liquid
  • Magnetic Resonance Imaging*
  • Magnetic Resonance Spectroscopy

Substances

  • Biological Products